Similarly, ADAR1 may also act as an immune checkpoint to modulate tumor sensitivity to immunotherapy: loss of ADAR1 in mouse B16 melanoma tumors could not only increase inflammation but also render tumors more sensitive to PD-1 antibodies, IFN, and radiation treatment. This evidence concerns the gene ADAR and neoplasm.